Marker Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
The offering is being made pursuant to a shelf registration statement, including a base prospectus, filed by Marker that was declared effective by the
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
This release contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release concerning the Company's expectations, plans, business outlook or future performance, and any other statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are "forward-looking statements." Forward-looking statements include statements regarding market risks and the satisfaction of customary closing conditions for an offering of securities. Forward-looking statements are by their nature subject to risks, uncertainties and other factors that could cause actual results to differ materially from those stated in such statements. Such risks, uncertainties and factors include, but are not limited to the risks set forth in the Company's most recent Annual Report on Form 10-K and other
View original content to download multimedia:http://www.prnewswire.com/news-releases/marker-therapeutics-inc-announces-pricing-of-public-offering-of-common-stock-301246161.html
Investor, Solebury Trout, Brian Korb, (646) 378-2923, email@example.com, Media, Solebury Trout, Amy Bonanno, (914) 450-0349, firstname.lastname@example.org